Precision BioSciences | pontifax-agtech

top of page

Pontifax AgTech Achieves 2nd Exit as Precision Biosciences IPOs with $870m Valuation

Pontifax AgTech Achieves 2nd Exit as Precision Biosciences IPOs with $870m Valuation

Precision Biosciences, the gene-editing startup, started trading on the Nasdaq stock exchange today after raising a $126.4 million IPO,...

Precision BioSciences Announces Collaboration to Develop Therapies Against Hepatitis B

Precision BioSciences Announces Collaboration to Develop Therapies Against Hepatitis B

FOSTER CITY, Calif. & DURHAM, N.C.--(BUSINESS WIRE)--Gilead Sciences (Nasdaq: GILD) and Precision BioSciences announced today that the...

Recent Posts

Kate Farms Appoints Christina J. Valentine to Chief Medical Officer

Kate Farms Announces Launch of First Whole Food Blended Meals

AgBiome Leverages Ginkgo Strain Optimization Services to Optimize Agricultural Biological Pipeline

World Agri-Tech Gold Partner

Pairwise Welcomes Healthy Snack Brand Executive To Board Of Directors

Tropic Biosciences Spins out Laverock Therapeutics to develop next-gen Programmable Cell Therapies

Pontifax AgTech is now Aliment Capital

AgBiome receives designation as a Certified B Corporation

"Fabric raises $200m at $1b+ valuation for robotics-based fulfillment tech"

Novozymes & Anuvia PLant nutrients join forces to bring biobased nutrients to commercial agricuture

Archive

bottom of page